Literature DB >> 19302184

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.

Masato Yoneda1, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Koji Fujita, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury in many countries. Genetic factors are important for the development of NAFLD, as well as environmental factors. Recently an angiotensin II type 1 receptor (AGTR1) has been recognized as important in the aetiology of fibrosis in the liver.
OBJECTIVE: In this study we investigated the association between angiotensin II type 1 receptor gene polymorphism (ATGR1) and NAFLD.
METHODS: One hundred and sixty-seven NAFLD patients [106 with nonalcoholic steatohepatitis (NASH) and 61 with simple steatosis] with a positive diagnosis by liver biopsy and 435 healthy control subjects were recruited in this study.
RESULTS: We investigated 12 single nucleotide polymorphisms (SNPs) of the ATGR1 gene, among which rs3772622 showed the lowest P-value of allele frequency model (P=0.0000012) with an odds ratio (95% confidence interval) of 1.95 (1.49-2.55). Five SNPs (rs3772622, rs3772633, rs2276736, rs3772630 and rs3772627) were significantly associated with NAFLD, even when the most conservative Bonferroni's correction was applied. Linkage disequilibrium analysis revealed that SNP rs3772622 and another four SNPs (rs3772633, rs2276736, rs3772630 and rs3772627) were in the same block. We investigated the association between rs3772622 genotypes and the fibrosis index. The results of the analysis revealed an additive increase of the fibrosis index in the patients with the A allele of rs3772622.
CONCLUSIONS: This is the first report to demonstrate the genetic variations in ATGR1 that may influence the risk of NAFLD and liver fibrosis in NAFLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302184     DOI: 10.1111/j.1478-3231.2009.01988.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  30 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Genetic and epigenetic mechanisms of NASH.

Authors:  Mohammed Eslam; Jacob George
Journal:  Hepatol Int       Date:  2015-12-18       Impact factor: 6.047

3.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

4.  Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Oguzhan Ozturk; Yasar Colak; Ebubekir Senates; Yusuf Yilmaz; Celal Ulasoglu; Levent Doganay; Seyma Ozkanli; Yasemin Musteri Oltulu; Ender Coskunpinar; Ilyas Tuncer
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 5.  Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

Authors:  Tyler J Severson; Siddesh Besur; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

6.  Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects.

Authors:  Maple M Fung; Fangwen Rao; Sameer Poddar; Manjula Mahata; Srikrishna Khandrika; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

Review 7.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.

Authors:  Hisamitsu Miyaaki; Kazuhiko Nakao
Journal:  Clin J Gastroenterol       Date:  2017-03-13

9.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

Review 10.  Pathogenesis of non-alcoholic fatty liver disease.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  QJM       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.